The Cremins lab investigates the epigenetic mechanisms regulating development and function of the mammalian central nervous system. We map and analyze neuronal epigenomes in three-dimensions using quantitative, genome-wide technologies. We also perturb epigenomes by employing state-of-the art genetic engineering strategies (e.g. CRISPR/Cas9, optoepigenetics). To test our hypotheses, we primarily use embryonic and induced pluripotent stem cell models of neuronal differentiation and disease. Our long-term goal is to discover how genome architecture controls genome function, applying this to study fundamental mechanisms controlling neuronal phenotype and, by extension, the onset and progression of neurodegenerative and neurodevelopmental disease states.

Linda Zhou from the Cremins lab is the recipient of an NIH F30 Grant 
starting September 2019. Congratulations Linda!

Zoltan Simandi and Harshini Chandrasekhar attend the Columbia single cell sequencing analysis boot camp.

Miriam Minsk is the recipient of the best research presentation award for her summer Rachleff scholar’s research. Congratulations to Miriam and her mentor Linda Zhou!

Jon Beagan presents his work at the Neuroepigenetics interest group in the Epigenetics Institute.

Linda Zhou presents her work for the Epigenetics Institute monthly seminar series.

Jennifer presents the lab’s work at the Evolution and 
Function of higher-order chromosomes meeting at the Institut Pasteur in 
Paris France.

logos  

 

Our work is supported by the New York Stem Cell Foundation, the Alfred P. Sloan Foundation, the National Science Foundation, an NIH New Innovator Award through the National Institute of Mental Health and the NIH 4D Nucleome Common Fund Initiative.